医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

Jinchi Biotech Ltd Launched Its ANDRIAS E-Commerce Flagship Store in Tmall

2014年09月19日 PM09:00
このエントリーをはてなブックマークに追加


 

ZHANGJIAJIE, China

Jinchi Biotech Ltd. had opened its ANDRIAS E-Commerce Flagship Store in Tmall.com (ANDRIAS Tmall Flagship Store Website: XIANGNI.TMALL.COM). As the unique brand of giant salamander active skincare products, ANDRIAS had started its E-Commerce marketing.

With the grand opening, ANDRIAS Tmall Flagship Store is carrying out the ‘Grand Opening September’ promotional activities. From September 19th, 2014 to October 18th, 2014, free shipping on all products; RMB 10 off by purchasing RMB 199, RMB 20 off by purchasing RMB 299, RMB 50 off by purchasing RMB 499; chances to win our amazing gift such as ANDRIAS Skin Care testing pack, Lucky Salamander Wallet, Lucky Salamander Key Chain etc.

ANDRIAS plans to exceed RMB 2,500,000 on the sales revenue by the end of 2014. At present, ANDRIAS brand promotion is being carried out in multiple platforms including zhitongche.taobao.com, zuanshi.taobao.com, ju.taobao.com, ad.alimama.com, try.taobao.com, zhe800.com, TV, MSG, and Weibo etc. In addition, until the end of 2014, there are many E-Shopping Festival Events coming up, such as ‘Grand Opening Celebrating’, ’11.11 E-Shopping Carnival’, ‘Year End Hoarding Festival’ and so on. Jinchi Biotech Ltd. is building the best salamander skin care products brand – ANDRIAS.

ABOUT JINCHI

www.jc-biotech.com

Owning the world’s only Giant Salamander Museum, Jinchi Biotech Ltd. mainly specialized in the R&D of giant salamander related biotech products with more than 40 skincare and health products under two product lines, namely SHINIQUE and ANDRIAS. With strong scientific research background and a comprehensive business model, Jinchi Biotech Ltd. values virtue and goodwill, commits to deliver quality products to consumers, and devotes to the health, beauty and biomedical industries.

Disclaimer

The statements contained herein are forward-looking statements that are subject to risks and uncertainties that could cause actual results to differ materially from those expressed in the forward-looking statements.

Photos/Multimedia Gallery Available: http://www.businesswire.com/multimedia/home/20140919005279/en/

CONTACT

Jinchi Biotech Ltd.
Chan Luo, +86-731-8979-2661
ir@jc-biotech.com

同じカテゴリーの記事 

  • Hyperfine, Inc. Takes the Stage at ISMRM with Seventeen Abstracts Assessing the Potential of Using Swoop® System Images Across Multiple Care Settings and Clinical Conditions
  • ReNAgade Therapeutics宣布在ASGCT第27届年会上发表演讲
  • ReNAgade TherapeuticsがASGCT第27回年次総会でのプレゼンテーションの内容を発表
  • BeiGene Receives European Commission Approval for Tislelizumab as Treatment for Non-Small Cell Lung Cancer
  • The 2024 Japan Prize Award Ceremony Is Held with Their Majesties the Emperor and Empress of Japan in Attendance